Press Releases

CyberKnife® System Provides Long-term Disease Control for Prostate Cancer Patients

Prospective, Multi-institutional Study Shows CyberKnife SBRT Treatment Results in Low PSA Nadir for Low- and Intermediate-risk Prostate Cancer Patients

Read More »
Accuray to Participate in the 2017 RBC Capital Markets Healthcare Conference on February 22, 2017 SUNNYVALE, Calif., February 13, 2017-- Accuray Incorporated (NASDAQ: ARAY), announced today that Kevin Waters, Senior Vice President and Chief Financial Officer, is scheduled to meet with investors one-on-one at the 2017 RBC Capital Markets Healthcare Conference in New York on Wednesday, February 22, 2017. Read More »
The Accuray Radixact™ System Receives Shonin Approval SUNNYVALE, Calif., February 8, 2017 – Accuray Incorporated (NASDAQ: ARAY) announced today that it has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its Radixact™ Treatment Delivery System, Accuray Precision™ Treatment Planning System and iDMS™ Data Management System. Together, the treatment delivery system and software solutions enable clinicians to provide highly precise treatment, efficiently, for a wider range of cancer patients, including those undergoing retreatment. This new Radixact™ platform is now available in Japan, in certain markets in the European Union, and in the U.S. market. Read More »
Accuray Grows Second Quarter Gross Orders 17%; Backlog Up 16% YoY SUNNYVALE, Calif., January 31, 2017 – Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the second fiscal quarter and six months ended December 31, 2016. Read More »
Miami Cancer Institute Treats First Cancer Patients with the Accuray Radixact™ System SUNNYVALE, Calif., January 26, 2017 – Accuray Incorporated (NASDAQ: ARAY) announced today that Miami Cancer Institute, a part of Baptist Health South Florida, is now treating patients using the new, uniquely "smart" Radixact™ Treatment Delivery System, fully integrated with the new Accuray Precision™ Treatment Planning System and iDMS™ Data Management System. Miami Cancer Institute selected the Radixact platform for its new, state-of-the-art treatment center because it offers leading edge, advanced treatment faster and expands access for more patients, while providing the foundation for anticipated clinical capabilities in the future Read More »
Accuray Continues to Set the Industry Standard for Customer Satisfaction SUNNYVALE, Calif., January 19, 2017 – Accuray Incorporated (Nasdaq: ARAY) announced today that its CyberKnife® and TomoTherapy® Systems continue to set the bar for excellence in customer satisfaction. Read More »
Accuray to Report Fiscal 2017 Second Quarter Financial Results on January 31, 2017

SUNNYVALE, CALIF., January 17, 2017—Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal second quarter ended December 31, 2016 on Tuesday, January 31, 2017 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.

Read More »
Accuray to Present at JP Morgan’s 35th Annual Healthcare Conference on January 11, 2017 SUNNYVALE, Calif., January 10, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will present at JP Morgan’s 35th Annual Healthcare Conference on Wednesday, January 11, 2017 at the Westin St. Francis Hotel in San Francisco. Read More »

Pages